Truist Financial’s SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $209K | Buy |
5,158
+17
| +0.3% | +$690 | ﹤0.01% | 2379 |
|
|
2025
Q1 | $225K | Sell |
5,141
-436
| -8% | -$19.1K | ﹤0.01% | 2280 |
|
|
2024
Q4 | $240K | Buy |
5,577
+93
| +2% | +$4K | ﹤0.01% | 2263 |
|
|
2024
Q3 | $243K | Buy |
+5,484
| New | +$243K | ﹤0.01% | 2234 |
|
|
2022
Q1 | – | Sell |
-7,688
| Closed | -$355K | – | 2824 |
|
|
2021
Q4 | $355K | Sell |
7,688
-2,443
| -24% | -$113K | ﹤0.01% | 2215 |
|
|
2021
Q3 | $481K | Sell |
10,131
-7,986
| -44% | -$379K | ﹤0.01% | 2004 |
|
|
2021
Q2 | $938K | Sell |
18,117
-2,800
| -13% | -$145K | ﹤0.01% | 1680 |
|
|
2021
Q1 | $1.05M | Sell |
20,917
-121
| -0.6% | -$6.09K | ﹤0.01% | 1555 |
|
|
2020
Q4 | $1.1M | Sell |
21,038
-6,881
| -25% | -$358K | ﹤0.01% | 1421 |
|
|
2020
Q3 | $1.21M | Buy |
27,919
+9,583
| +52% | +$417K | ﹤0.01% | 1285 |
|
|
2020
Q2 | $788K | Buy |
+18,336
| New | +$788K | ﹤0.01% | 1389 |
|